Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 807-085-0 | CAS number: 1004297-30-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- mouse local lymph node assay (LLNA)
- Species:
- mouse
- Strain:
- CBA
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Harlan Laboratories B.V.; Host /The Netherlands
- Age at study initiation: 1st pre-test: 10 - 11 weeks (beginning of treatment)
2nd pre-test: 8-9 weeks (beginning of treatment) Main study: 11 - 12 weeks (beginning of treatment)
- Housing: group (Makrolon Type II / III)
- Diet (e.g. ad libitum): 2018C Teklad Global 18% protein rodent diet (certified), ad libitum
- Water (e.g. ad libitum): tap water, ad libitum
- Acclimation period: at least 5 days prior
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 +/- 2°C
- Humidity (%): approx. 45-65 %
- Photoperiod (hrs dark / hrs light): 12/12 - Vehicle:
- dimethylformamide
- Concentration:
- 2, 5 and 10% (As the purity of the test item was approx. 50%, the actual tested concentrations were approx. 1, 2.5 and 5% (w/w))
- No. of animals per dose:
- 5 females
- Details on study design:
- Methode:
Each test group of mice was treated by (epidermal) topical application to the dorsal surface of each ear with test item concentrations of 2, 5, and 10% in DMF (actual concentration of 1, 2.5 and 5%). The application volume, 25 μL/ear/day, was spread over the entire dorsal surface (∅ ∼ 8 mm) of each ear once daily for three consecutive days. A further group of mice (control animals) was treated with an equivalent volume of the relevant vehicle alone (control animals).
Five days after the first topical application (day 6) 250 μL of phosphate-buffered saline containing 19.8 μCi of 3H-methyl thymidine (equivalent to 79.2 μCi/mL 3HTdR) were injected into each test and control mouse via the tail vein.
Approximately five hours after treatment with 3HTdR all mice were euthanised by using CO2, which was, after harvesting of the lymph nodes, followed by cervical dislocation to ensure death. - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
- Statistics:
- A statistical analysis was conducted on the DPM values, the ear weights, the lymph node weights and the lymph node cell count to assess whether the difference was statistically significant between the test item groups and negative control group. For all statistical calculations custom made statistical program ´R` Decision Tree was used. Statistical significance was set at the five per cent level (p < 0.05).
The Dean-Dixon-Test and the Grubb’s test were used for detection of possible outliers (performed with custom made statistical program ´R` Decision Tree).
However, both biological and statistical significance were considered together. - Positive control results:
- The sensitivity and reliability of the experimental technique employed was assessed by use of α-hexyl cinnamaldehyde dissolved in acetone/olive oil (4+1, v/v) (compound listed in OECD 429 Guideline) which is known to have skin sensitisation properties in mice. The periodic positive control experiment was performed using CBA/CaOlaHsd mice in April 2014.
- Parameter:
- SI
- Remarks on result:
- other: see Remark
- Remarks:
- In this study Stimulation Indices (S.I.) of 1.11, 1.46, and 2.64 were determined with the test item at concentrations of 2, 5, and 10% (w/w) in DMF, respectively (actual concentration of approx. 1, 2.5 and 5% (w/w)). A clear dose response was observed.
- Executive summary:
The test item Trimethylcyclohexylammonium sulfate, aqueous solution 50 wt.% was not a skin sensitiser under the test conditions of this study.
Reference
Lymph Node Weights and Cell Counts
The measured lymph node weights and -cell counts of all animals treated were recorded after sacrifice. A statistically significant increase in lymph node weight was observed in the high dose group in comparison to the vehicle control group. A statistically significant increase in lymph node cell count was observed in the mid and high dose group in comparison to the vehicle control group. Furthermore, the cut-off value of 1.55 for a positive response regarding the lymph node cell count index reported for BALB/c mice was exceeded in the high dose group (index of 1.72). The statistically significant increases were considered not to be biologically relevant, as none of the affected dose groups produced an S.I. above 3.
Ear Weights
The measured ear weight of all animals treated was recorded on test day 6 (after necropsy). A statistically significant or biologically relevant increase in ear weights was not observed in any treated group in comparison to the vehicle control group. Furthermore, for BALB/c mice, a cut-off value of 1.1 for the ear weight index was reported for a positive response regarding ear skin irritation. None of the indices determined for the test item treated groups exceeded this threshold.
Test item concentration* |
Group Calculation |
||
Mean DPM per animal (2 lymph nodes)a) |
SD |
S.I. |
|
Vehicle Control Group (DMF) |
957.0 |
191.3 |
1.00 |
2% Trimethylcyclohexylammonium sulfate, aqueous solution 50 wt.%
|
1064.2 |
279.8 |
1.11 |
5% Trimethylcyclohexylammonium sulfate, aqueous solution 50 wt.%
|
1400.8 |
255.0 |
1.46 |
10% Trimethylcyclohexylammonium sulfate, aqueous solution 50 wt.%
|
2528.0 |
449.8 |
2.64S |
a) Mean DPM/animal was determined by dividing the sum of the measured values from lymph nodes of all animals within a group by the number of animals in that group (5 animals)
S Mean DPM value for the group was according to the ANOVA (Dunnett-test) significantly higher than the corresponding control value.
* As the purity of the test item was approx. 50%, the actual tested concentrations were approx. 1, 2.5 and 5% (w/w).
The EC3 value could not be calculated, since all S.I.´s are below the threshold value of 3.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
- Additional information:
In this study the test item Trimethylcyclohexylammonium sulfate, aqueous solution 50 wt.% was assessed for its skin sensitising potential using the Local Lymph Node Assay (LLNA) in mice. Test item solution at different concentrations was prepared in the vehicle DMF.
For this purpose a local lymph node assay was performed using test item concentrations of 2, 5, and 10% (w/w). As the purity of the test item was approx. 50%, the actual tested concentrations were approx. 1, 2.5 and 5% (w/w).
In this study Stimulation Indices (S.I.) of 1.11, 1.46, and 2.64 were determined with the test item at concentrations of 2, 5, and 10% (w/w) in DMF, respectively (actual concentration of approx. 1, 2.5 and 5% (w/w)). A clear dose response was observed.
The test item Trimethylcyclohexylammonium sulfate, aqueous solution 50 wt.% was thus not a skin sensitiser under the test conditions of this study.
Migrated from Short description of key information:
LLNA: not sensitising (BASF, 2015)
Justification for selection of skin sensitisation endpoint:
GLP guideline study
Justification for classification or non-classification
Based on the available studies data on skin sensitization testing, the test item would not have to be classified and labelled according to Directive 67/548/EEC (DSD) and according to Regulation (EC) No 1272/2008 (CLP).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.